{"id":22831,"date":"2026-08-21T09:18:20","date_gmt":"2026-08-21T07:18:20","guid":{"rendered":"https:\/\/mic-site.labiux.com\/reto-slimibu-alianse-par-apstiprinato-planu-reto-slimibu-joma-gandarita-bet-baziga-par-finansejuma-garantiju-trukumu\/"},"modified":"2026-08-21T09:18:20","modified_gmt":"2026-08-21T07:18:20","slug":"reto-slimibu-alianse-par-apstiprinato-planu-reto-slimibu-joma-gandarita-bet-baziga-par-finansejuma-garantiju-trukumu","status":"publish","type":"post","link":"https:\/\/farmacija-mic.lv\/en\/reto-slimibu-alianse-par-apstiprinato-planu-reto-slimibu-joma-gandarita-bet-baziga-par-finansejuma-garantiju-trukumu\/","title":{"rendered":"Reto slim\u012bbu alianse par apstiprin\u0101to pl\u0101nu reto slim\u012bbu jom\u0101 gandar\u012bta, bet ba\u017e\u012bga par finans\u0113juma garantiju tr\u016bkumu"},"content":{"rendered":"<div class=\"wp-block-labiux-legacy-html legacy-content\">\n<p>Latvijas Reto slim\u012bbu alianse ir gandar\u012bta par vald\u012bb\u0101 apstiprin\u0101to pl\u0101nu reto slim\u012bbu jom\u0101 2026.-2027. gadam, ta\u010du ba\u017e\u012bjas par t\u0101 \u012bsteno\u0161anai nepiecie\u0161am\u0101 finans\u0113juma garantiju tr\u016bkumu, a\u0123ent\u016brai LETA pauda alianses valdes priek\u0161s\u0113d\u0113t\u0101js<strong> Juris Beikmanis<\/strong>.<\/p>\n<p>Alianse piedal\u012bjusies pl\u0101na izstr\u0101des proces\u0101, t\u0101d\u0113\u013c esot liels prieks, ka dokuments beidzot apstiprin\u0101ts. Reiz\u0113 Beikmanis nor\u0101d\u012bja, ka vismaz pusgadu, iesp\u0113jams, pat ilg\u0101k gaid\u012bts, kad pl\u0101ns tiks virz\u012bts apstiprin\u0101\u0161anai.<\/p>\n<p>Prieku par pl\u0101na apstiprin\u0101\u0161anu gan mazinot r\u012bkojum\u0101 iek\u013cautais punkts, kas paredz jaut\u0101jumu par papildu valsts bud\u017eeta l\u012bdzek\u013cu pie\u0161\u0137ir\u0161anu 2027. gad\u0101 un turpm\u0101k ik gadu skat\u012bt valsts bud\u017eeta sagatavo\u0161anas proces\u0101 kop\u0101 ar visu ministriju un centr\u0101lo valsts iest\u0101\u017eu priorit\u0101ro pas\u0101kumu pieteikumiem atbilsto\u0161i valsts finansi\u0101laj\u0101m iesp\u0113j\u0101m. &#8220;Tas ir sol\u012bjums bez seguma,&#8221; sac\u012bja Beikmanis.<\/p>\n<p>Vi\u0146\u0161 skaidroja, ka iepriek\u0161\u0113jos pl\u0101nos katram gadam noteikts nepiecie\u0161amais finans\u0113juma apjoms un t\u0101 pieaugums. Savuk\u0101rt 2026. gad\u0101, p\u0113c Beikma\u0146a teikt\u0101, papildu apstiprin\u0101ti tikai aptuveni 213 000 eiro, turkl\u0101t tas esot Eiropas Savien\u012bbas, nevis valsts finans\u0113jums.<\/p>\n<p>P\u0113c alianses apr\u0113\u0137iniem, iepriek\u0161\u0113j\u0101 period\u0101 no 202 medikamentu pieejam\u012bbai pras\u012bt\u0101 finans\u0113juma izpilde bijusi tikai aptuveni 18%. T\u0101d\u0113j\u0101di at\u0161\u0137ir\u012bba starp pacientu \u0101rst\u0113\u0161anai nepiecie\u0161amo un faktiski pie\u0161\u0137irto finans\u0113jumu saglab\u0101jusies \u013coti liela.<\/p>\n<p>&#8220;Pl\u0101ns ir apstiprin\u0101ts &#8211; tas ir labi. Tas, ka nav naudas, ir \u013coti slikti. Atkal sa\u0146emam sol\u012bjumu kaut kad n\u0101kotn\u0113,&#8221; situ\u0101ciju raksturoja Beikmanis.<\/p>\n<p>Vi\u0146a v\u0113rt\u0113jum\u0101, r\u012bkojuma redakcija rada skaidru sign\u0101lu, ka nav zin\u0101ms, vai Vesel\u012bbas ministrijai (VM) izdosies rast pl\u0101na \u012bsteno\u0161anai nepiecie\u0161amo finans\u0113jumu. Past\u0101vot risks, ka 2027. gad\u0101, s\u0101kot darbu pie n\u0101kam\u0101 pl\u0101na, situ\u0101cija atk\u0101rtosies.<\/p>\n<p>&#8220;Tas ir &#8220;deja vu&#8221; &#8211; pien\u0101ks 2027. gads, str\u0101d\u0101sim pie jaun\u0101 pl\u0101na turpm\u0101kajiem gadiem, un b\u016bs tie\u0161i t\u0101da pati situ\u0101cija,&#8221; pauda alianses vad\u012bt\u0101js.<\/p>\n<p>Beikmanis uzsv\u0113ra, ka pa\u0161laik izveidojusies rinda ar medikamentiem, kuri jau atz\u012bti par izmaksu efekt\u012bviem, ta\u010du finans\u0113juma tr\u016bkuma d\u0113\u013c pacienti tos nevar sa\u0146emt. P\u0113c vi\u0146a teikt\u0101, reto slim\u012bbu medikamentu kompens\u0113jamo z\u0101\u013cu R saraksta papla\u0161in\u0101\u0161anai kop\u0161 2023. l\u012bdz 2025. gadam, b\u016btu biju\u0161i nepiecie\u0161ami aptuveni desmit l\u012bdz 12 miljoni eiro. Tom\u0113r p\u0113rn \u0161im m\u0113r\u0137im pie\u0161\u0137irti aptuveni divi miljoni eiro, bet \u0161ogad papildu finans\u0113jums neesot pie\u0161\u0137irts visp\u0101r.<\/p>\n<p>&#8220;Izmaksu efekt\u012bvie medikamenti jau ir atz\u012bti un izg\u0101ju\u0161i v\u0113rt\u0113\u0161anas procesu. Pret\u012b ir pacients, kur\u0161 ir gatavs tos sa\u0146emt, bet rinda nekustas uz priek\u0161u,&#8221; situ\u0101ciju raksturoja Beikmanis.<\/p>\n<p>Turkl\u0101t da\u013ca vesel\u012bbas apr\u016bpei pie\u0161\u0137irt\u0101 finans\u0113juma tiekot izmantota iepriek\u0161\u0113jo gadu saist\u012bbu seg\u0161anai, t\u0101d\u0113\u013c faktiskais finans\u0113juma pieaugums jaunu pacientu \u0101rst\u0113\u0161anai esot v\u0113l maz\u0101ks. &#8220;M\u0113s faktiski neko nedab\u016bjam kl\u0101t,&#8221; vi\u0146\u0161 apgalvoja.<\/p>\n<p>Beikmanis skeptiski v\u0113rt\u0113ja pl\u0101n\u0101 noteikto m\u0113r\u0137i divu gadu laik\u0101 apmaks\u0101t visus gaid\u012b\u0161anas rind\u0101 eso\u0161os izmaksu efekt\u012bvos medikamentus, par kuriem veikts finan\u0161u apr\u0113\u0137ins. Vi\u0146am neesot skaidrs, k\u0101 \u0161o m\u0113r\u0137i iesp\u0113jams sasniegt bez atbilsto\u0161a finans\u0113juma.<\/p>\n<p>Vi\u0146\u0161 v\u0113rsa uzman\u012bbu ar\u012b uz to, ka valst\u012b neesot meh\u0101nisma terapijas turpin\u0101\u0161anai gad\u012bjumos, kad, piem\u0113ram, farm\u0101cijas uz\u0146\u0113mums p\u0101rtrauc pacientam bez maksas nodro\u0161in\u0101t efekt\u012bvu medikamentu. Valst\u012b neesot skaidras k\u0101rt\u012bbas, k\u0101 p\u0101r\u0146emt terapijas apmaksu, ja praks\u0113 jau pier\u0101d\u012bta t\u0101s efektivit\u0101te.<\/p>\n<p>Atsevi\u0161\u0137\u0101s situ\u0101cij\u0101s pacienti nepiecie\u0161amos l\u012bdzek\u013cus \u0101rst\u0113\u0161anai sav\u0101c ziedojumos, ta\u010du tas probl\u0113mu atrisinot tikai \u012bslaic\u012bgi. Ja terapija izr\u0101d\u0101s efekt\u012bva, bet valsts t\u0101s apmaksu nep\u0101r\u0146em, pacientam atk\u0101rtoti j\u0101l\u016bdz sabiedr\u012bbas atbalsts.<\/p>\n<p>Beikma\u0146a v\u0113rt\u0113jum\u0101, atbild\u012bba par finans\u0113juma atra\u0161anu tiek &#8220;nogr\u016bsta&#8221; VM, lai gan reto slim\u012bbu pacientu \u0101rst\u0113\u0161ana neesot tikai vienas ministrijas probl\u0113ma. Vi\u0146\u0161 apgalvoja, ka VM apr\u0113\u0137ina pas\u0101kumu \u012bsteno\u0161anai nepiecie\u0161amo summu, tom\u0113r p\u0113c Finan\u0161u ministrijas (FM) pras\u012bb\u0101m tai l\u012bdztekus j\u0101nor\u0101da ar\u012b kritiski nepiecie\u0161am\u0101 minim\u0101l\u0101 summa, kas m\u0113dzot b\u016bt pat \u010detras reizes maz\u0101ka.<\/p>\n<p>Alianses vad\u012bt\u0101js sal\u012bdzin\u0101ja, ka p\u0113rn slim\u012bbas un invalidit\u0101tes pabalstiem Labkl\u0101j\u012bbas ministrijas bud\u017eet\u0101 papildu pie\u0161\u0137irti 58 miljoni eiro, savuk\u0101rt vesel\u012bbas apr\u016bpei &#8211; tikai aptuveni desmit miljoni eiro.<\/p>\n<p>&#8220;T\u0101tad valsts ir gatava vienai poz\u012bcijai pie\u0161\u0137irt 58 miljonus eiro, lai cilv\u0113ki ilg\u0101k slimotu un k\u013c\u016btu par cilv\u0113kiem ar invalidit\u0101ti, nevis dot naudu, lai laikus nov\u0113rstu c\u0113loni?&#8221; retoriski vaic\u0101ja Beikmanis.<\/p>\n<p>Vi\u0146\u0161 uzsv\u0113ra, ka atbilsto\u0161i apl\u0113s\u0113m ret\u0101s slim\u012bbas dz\u012bves laik\u0101 var skart aptuveni 130 000 Latvijas iedz\u012bvot\u0101ju, lai gan ofici\u0101li re\u0123istr\u0113ti tikai aptuveni 26 000 pacientu. Turkl\u0101t slim\u012bba ietekm\u0113 ar\u012b pacientu \u0123imenes locek\u013cus, t\u0101d\u0113\u013c skarto cilv\u0113ku loks esot divas vai pat tr\u012bs reizes liel\u0101ks.<\/p>\n<p>&#8220;Grib\u0113tos, lai politi\u0137i saprot, ka 130 000 cilv\u0113ku nav nemaz tik maza sabiedr\u012bbas da\u013ca,&#8221; uzsv\u0113ra Beikmanis.<\/p>\n<p>Vi\u0146a v\u0113rt\u0113jum\u0101 Latvija reto slim\u012bbu pacientu apmierin\u0101t\u012bbas un apr\u016bpes pieejam\u012bbas r\u0101d\u012bt\u0101jos jau ilgsto\u0161i atrodas Eiropas reitingu lejasda\u013c\u0101. Savuk\u0101rt Lietuva esot apzin\u0101jusies probl\u0113mas nopietn\u012bbu un \u0161aj\u0101 jom\u0101 veikusi apjom\u012bgas invest\u012bcijas.<\/p>\n<p>Beikmanis atzina, ka pl\u0101na apstiprin\u0101\u0161ana pati par sevi ir noz\u012bm\u012bga, jo taj\u0101 iek\u013cauti konkr\u0113ti sasniedzamie r\u0101d\u012bt\u0101ji, uz kuriem iesp\u0113jams atsaukties pas\u0101kumu \u012bsteno\u0161an\u0101, tai skait\u0101 pras\u012bt rezult\u0101tus, saukt pie atbild\u012bbas, k\u0101 ar\u012b m\u0113\u0123in\u0101t rast tiem nepiecie\u0161amo finans\u0113jumu.<\/p>\n<p>Jau zi\u0146ots, ka vald\u012bba \u0161oned\u0113\u013c apstiprin\u0101jusi VM izstr\u0101d\u0101to Pl\u0101nu reto slim\u012bbu jom\u0101 2026.-2027. gadam. \u0160ogad t\u0101 pas\u0101kumus \u012bstenos par jau pie\u0161\u0137irtajiem l\u012bdzek\u013ciem, savuk\u0101rt 2027. gad\u0101 papildus nepiecie\u0161ami 16 988 608 eiro. No 2028. gada pl\u0101na pas\u0101kumiem ik gadu b\u016btu vajadz\u012bgi 16 258 001 eiro.<\/p>\n<p>Pl\u0101ns paredz uzlabot reto slim\u012bbu diagnostiku un \u0101rstniec\u012bbas pieejam\u012bbu, papla\u0161in\u0101t \u0123en\u0113tiskos izmekl\u0113jumus, veidot multidisciplin\u0101ras apr\u016bpes komandas universit\u0101\u0161u slimn\u012bc\u0101s un pilnveidot pacientu uzskaiti. L\u012bdz 2027. gadam iecer\u0113ts par vismaz 30% samazin\u0101t gaid\u012b\u0161anas laiku uz B\u0113rnu slimn\u012bcas Reto slim\u012bbu kabineta pakalpojumiem.<\/p>\n<p>Pieaugot kop\u0113jam kompens\u0113jamo medikamentu finans\u0113jumam, finans\u0113jumu paredz\u0113ts proporcion\u0101li palielin\u0101t ar\u012b reto slim\u012bbu medikamentiem. T\u0101d\u0113j\u0101di divu gadu laik\u0101 pl\u0101nots apmaks\u0101t visus gaid\u012b\u0161anas rind\u0101 eso\u0161os izmaksu efekt\u012bvos medikamentus, par kuriem veikts finan\u0161u apr\u0113\u0137ins, k\u0101 ar\u012b par 50% samazin\u0101t \u0101rst\u0113\u0161anas s\u0101k\u0161anu gaido\u0161o pacientu skaitu.<\/p>\n<p>FM iepriek\u0161 iebilda, ka turpm\u0101kajos gados papildu finans\u0113jums bez kompens\u0113jo\u0161iem pas\u0101kumiem var\u0113tu neb\u016bt pieejams, un aicin\u0101ja pl\u0101n\u0101 iek\u013caut tikai par jau pie\u0161\u0137irtajiem l\u012bdzek\u013ciem \u012bstenojamus pas\u0101kumus. Ar\u012b iepriek\u0161\u0113j\u0101 pl\u0101n\u0101 paredz\u0113tais finans\u0113juma pieaugums netika nodro\u0161in\u0101ts piln\u0101 apm\u0113r\u0101 &#8211; 2025. gad\u0101 kompens\u0113jamo medikamentu un materi\u0101lu apmaksai pie\u0161\u0137irti tikai 16% no pl\u0101not\u0101 finans\u0113juma.<\/p>\n<p>Atbilsto\u0161i Eiropas apl\u0113s\u0113m ar retu slim\u012bbu Latvij\u0101 var\u0113tu dz\u012bvot vid\u0113ji ap 130 000 cilv\u0113ku. \u0160\u0101 gada 14. apr\u012bl\u012b bija re\u0123istr\u0113ti 26 449 reto slim\u012bbu gad\u012bjumi, bet akt\u012bvi re\u0123istr\u0113to pacientu skaits bija 25 390.<\/p>\n<p>Avots: LETA<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Latvijas Reto slim\u012bbu alianse ir gandar\u012bta par vald\u012bb\u0101 apstiprin\u0101to pl\u0101nu reto slim\u012bbu jom\u0101 2026.-2027. gadam, ta\u010du ba\u017e\u012bjas par t\u0101 \u012bsteno\u0161anai nepiecie\u0161am\u0101 finans\u0113juma garantiju tr\u016bkumu, a\u0123ent\u016brai LETA pauda alianses valdes priek\u0161s\u0113d\u0113t\u0101js [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":13491,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"mic_cinema_image":0,"mic_focus":"","mic_cinema_focus":"","footnotes":"","_labiux_rail":0},"categories":[76,73],"tags":[2892,341],"mic_flag":[],"class_list":["post-22831","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-jaunakie-raksti","category-medikamentu-zinas","tag-beikmanis","tag-retas-slimibas"],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 5.0.4 - aioseo.com -->\n\t<meta name=\"description\" content=\"Latvijas Reto slim\u012bbu alianse ir gandar\u012bta par vald\u012bb\u0101 apstiprin\u0101to pl\u0101nu reto slim\u012bbu jom\u0101 2026.-2027. gadam, ta\u010du ba\u017e\u012bjas par t\u0101 \u012bsteno\u0161anai nepiecie\u0161am\u0101 finans\u0113juma garantiju tr\u016bkumu, a\u0123ent\u016brai LETA pauda alianses valdes priek\u0161s\u0113d\u0113t\u0101js Juris Beikmanis. Alianse piedal\u012bjusies pl\u0101na izstr\u0101des proces\u0101, t\u0101d\u0113\u013c esot liels prieks, ka dokuments beidzot apstiprin\u0101ts. Reiz\u0113 Beikmanis nor\u0101d\u012bja, ka vismaz pusgadu, iesp\u0113jams, pat ilg\u0101k gaid\u012bts,\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"author\" content=\"admin\"\/>\n\t<link rel=\"canonical\" href=\"https:\/\/farmacija-mic.lv\/en\/reto-slimibu-alianse-par-apstiprinato-planu-reto-slimibu-joma-gandarita-bet-baziga-par-finansejuma-garantiju-trukumu\/\" \/>\n\t\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 5.0.4\" \/>\n\t\t<meta property=\"og:locale\" content=\"en_US\" \/>\n\t\t<meta property=\"og:site_name\" content=\"Medikamentu Inform\u0101cijas Centrs\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"Reto slim\u012bbu alianse par apstiprin\u0101to pl\u0101nu reto slim\u012bbu jom\u0101 gandar\u012bta, bet ba\u017e\u012bga par finans\u0113juma garantiju tr\u016bkumu - Medikamentu Inform\u0101cijas Centrs\" \/>\n\t\t<meta property=\"og:description\" content=\"Latvijas Reto slim\u012bbu alianse ir gandar\u012bta par vald\u012bb\u0101 apstiprin\u0101to pl\u0101nu reto slim\u012bbu jom\u0101 2026.-2027. gadam, ta\u010du ba\u017e\u012bjas par t\u0101 \u012bsteno\u0161anai nepiecie\u0161am\u0101 finans\u0113juma garantiju tr\u016bkumu, a\u0123ent\u016brai LETA pauda alianses valdes priek\u0161s\u0113d\u0113t\u0101js Juris Beikmanis. Alianse piedal\u012bjusies pl\u0101na izstr\u0101des proces\u0101, t\u0101d\u0113\u013c esot liels prieks, ka dokuments beidzot apstiprin\u0101ts. Reiz\u0113 Beikmanis nor\u0101d\u012bja, ka vismaz pusgadu, iesp\u0113jams, pat ilg\u0101k gaid\u012bts,\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/farmacija-mic.lv\/en\/reto-slimibu-alianse-par-apstiprinato-planu-reto-slimibu-joma-gandarita-bet-baziga-par-finansejuma-garantiju-trukumu\/\" \/>\n\t\t<meta property=\"og:image\" content=\"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/2023\/01\/reto-slimibu-pacients-patient.png\" \/>\n\t\t<meta property=\"og:image:secure_url\" content=\"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/2023\/01\/reto-slimibu-pacients-patient.png\" \/>\n\t\t<meta property=\"og:image:width\" content=\"1000\" \/>\n\t\t<meta property=\"og:image:height\" content=\"667\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2026-08-21T07:18:20+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2026-08-21T07:18:20+00:00\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:title\" content=\"Reto slim\u012bbu alianse par apstiprin\u0101to pl\u0101nu reto slim\u012bbu jom\u0101 gandar\u012bta, bet ba\u017e\u012bga par finans\u0113juma garantiju tr\u016bkumu - Medikamentu Inform\u0101cijas Centrs\" \/>\n\t\t<meta name=\"twitter:description\" content=\"Latvijas Reto slim\u012bbu alianse ir gandar\u012bta par vald\u012bb\u0101 apstiprin\u0101to pl\u0101nu reto slim\u012bbu jom\u0101 2026.-2027. gadam, ta\u010du ba\u017e\u012bjas par t\u0101 \u012bsteno\u0161anai nepiecie\u0161am\u0101 finans\u0113juma garantiju tr\u016bkumu, a\u0123ent\u016brai LETA pauda alianses valdes priek\u0161s\u0113d\u0113t\u0101js Juris Beikmanis. Alianse piedal\u012bjusies pl\u0101na izstr\u0101des proces\u0101, t\u0101d\u0113\u013c esot liels prieks, ka dokuments beidzot apstiprin\u0101ts. Reiz\u0113 Beikmanis nor\u0101d\u012bja, ka vismaz pusgadu, iesp\u0113jams, pat ilg\u0101k gaid\u012bts,\" \/>\n\t\t<meta name=\"twitter:image\" content=\"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/2023\/01\/reto-slimibu-pacients-patient.png\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/reto-slimibu-alianse-par-apstiprinato-planu-reto-slimibu-joma-gandarita-bet-baziga-par-finansejuma-garantiju-trukumu\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/category\\\/medikamentu-zinas\\\/#listItem\",\"name\":\"Medikamenti\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/category\\\/medikamentu-zinas\\\/#listItem\",\"position\":2,\"name\":\"Medikamenti\",\"item\":\"https:\\\/\\\/farmacija-mic.lv\\\/category\\\/medikamentu-zinas\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/reto-slimibu-alianse-par-apstiprinato-planu-reto-slimibu-joma-gandarita-bet-baziga-par-finansejuma-garantiju-trukumu\\\/#listItem\",\"name\":\"Reto slim\\u012bbu alianse par apstiprin\\u0101to pl\\u0101nu reto slim\\u012bbu jom\\u0101 gandar\\u012bta, bet ba\\u017e\\u012bga par finans\\u0113juma garantiju tr\\u016bkumu\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#listItem\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/reto-slimibu-alianse-par-apstiprinato-planu-reto-slimibu-joma-gandarita-bet-baziga-par-finansejuma-garantiju-trukumu\\\/#listItem\",\"position\":3,\"name\":\"Reto slim\\u012bbu alianse par apstiprin\\u0101to pl\\u0101nu reto slim\\u012bbu jom\\u0101 gandar\\u012bta, bet ba\\u017e\\u012bga par finans\\u0113juma garantiju tr\\u016bkumu\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/category\\\/medikamentu-zinas\\\/#listItem\",\"name\":\"Medikamenti\"}}]},{\"@type\":\"NewsArticle\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/reto-slimibu-alianse-par-apstiprinato-planu-reto-slimibu-joma-gandarita-bet-baziga-par-finansejuma-garantiju-trukumu\\\/#newsarticle\",\"name\":\"Reto slim\\u012bbu alianse par apstiprin\\u0101to pl\\u0101nu reto slim\\u012bbu jom\\u0101 gandar\\u012bta, bet ba\\u017e\\u012bga par finans\\u0113juma garantiju tr\\u016bkumu - Medikamentu Inform\\u0101cijas Centrs\",\"headline\":\"Reto slim\\u012bbu alianse par apstiprin\\u0101to pl\\u0101nu reto slim\\u012bbu jom\\u0101 gandar\\u012bta, bet ba\\u017e\\u012bga par finans\\u0113juma garantiju tr\\u016bkumu\",\"author\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/author\\\/admin\\\/#author\"},\"publisher\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#organization\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/farmacija-mic.lv\\\/wp-content\\\/uploads\\\/2023\\\/01\\\/reto-slimibu-pacients-patient.png\",\"width\":1000,\"height\":667},\"datePublished\":\"2026-08-21T09:18:20+03:00\",\"dateModified\":\"2026-08-21T09:18:20+03:00\",\"inLanguage\":\"en-US\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/reto-slimibu-alianse-par-apstiprinato-planu-reto-slimibu-joma-gandarita-bet-baziga-par-finansejuma-garantiju-trukumu\\\/#webpage\"},\"isPartOf\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/reto-slimibu-alianse-par-apstiprinato-planu-reto-slimibu-joma-gandarita-bet-baziga-par-finansejuma-garantiju-trukumu\\\/#webpage\"},\"articleSection\":\"Jaun\\u0101kie raksti, Medikamenti, Beikmanis, ret\\u0101s slim\\u012bbas\",\"dateline\":\"Published on August 21, 2026.\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#organization\",\"name\":\"Medikamentu Inform\\u0101cijas Centrs\",\"description\":\"Farm\\u0101cijas nozares port\\u0101ls farmaceitiem un \\u0101rstiem. Zi\\u0146as, normat\\u012bvie akti, pas\\u0101kumi un t\\u0101l\\u0101kizgl\\u012bt\\u012bba vienuviet kop\\u0161 2001. gada.\",\"url\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/author\\\/admin\\\/#author\",\"url\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/author\\\/admin\\\/\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/reto-slimibu-alianse-par-apstiprinato-planu-reto-slimibu-joma-gandarita-bet-baziga-par-finansejuma-garantiju-trukumu\\\/#authorImage\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/be3221a6fac131657111728b4d912a877ec158b123d5db3afef3bd8a59784ece?s=96&d=mm&r=g\",\"width\":96,\"height\":96,\"caption\":\"admin\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/reto-slimibu-alianse-par-apstiprinato-planu-reto-slimibu-joma-gandarita-bet-baziga-par-finansejuma-garantiju-trukumu\\\/#webpage\",\"url\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/reto-slimibu-alianse-par-apstiprinato-planu-reto-slimibu-joma-gandarita-bet-baziga-par-finansejuma-garantiju-trukumu\\\/\",\"name\":\"Reto slim\\u012bbu alianse par apstiprin\\u0101to pl\\u0101nu reto slim\\u012bbu jom\\u0101 gandar\\u012bta, bet ba\\u017e\\u012bga par finans\\u0113juma garantiju tr\\u016bkumu - Medikamentu Inform\\u0101cijas Centrs\",\"description\":\"Latvijas Reto slim\\u012bbu alianse ir gandar\\u012bta par vald\\u012bb\\u0101 apstiprin\\u0101to pl\\u0101nu reto slim\\u012bbu jom\\u0101 2026.-2027. gadam, ta\\u010du ba\\u017e\\u012bjas par t\\u0101 \\u012bsteno\\u0161anai nepiecie\\u0161am\\u0101 finans\\u0113juma garantiju tr\\u016bkumu, a\\u0123ent\\u016brai LETA pauda alianses valdes priek\\u0161s\\u0113d\\u0113t\\u0101js Juris Beikmanis. Alianse piedal\\u012bjusies pl\\u0101na izstr\\u0101des proces\\u0101, t\\u0101d\\u0113\\u013c esot liels prieks, ka dokuments beidzot apstiprin\\u0101ts. Reiz\\u0113 Beikmanis nor\\u0101d\\u012bja, ka vismaz pusgadu, iesp\\u0113jams, pat ilg\\u0101k gaid\\u012bts,\",\"inLanguage\":\"en-US\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/reto-slimibu-alianse-par-apstiprinato-planu-reto-slimibu-joma-gandarita-bet-baziga-par-finansejuma-garantiju-trukumu\\\/#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/author\\\/admin\\\/#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/author\\\/admin\\\/#author\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/farmacija-mic.lv\\\/wp-content\\\/uploads\\\/2023\\\/01\\\/reto-slimibu-pacients-patient.png\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/reto-slimibu-alianse-par-apstiprinato-planu-reto-slimibu-joma-gandarita-bet-baziga-par-finansejuma-garantiju-trukumu\\\/#mainImage\",\"width\":1000,\"height\":667},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/reto-slimibu-alianse-par-apstiprinato-planu-reto-slimibu-joma-gandarita-bet-baziga-par-finansejuma-garantiju-trukumu\\\/#mainImage\"},\"datePublished\":\"2026-08-21T09:18:20+03:00\",\"dateModified\":\"2026-08-21T09:18:20+03:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/\",\"name\":\"Medikamentu Inform\\u0101cijas Centrs\",\"description\":\"Farm\\u0101cijas nozares port\\u0101ls farmaceitiem un \\u0101rstiem. Zi\\u0146as, normat\\u012bvie akti, pas\\u0101kumi un t\\u0101l\\u0101kizgl\\u012bt\\u012bba vienuviet kop\\u0161 2001. gada.\",\"inLanguage\":\"en-US\",\"publisher\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"Reto slim\u012bbu alianse par apstiprin\u0101to pl\u0101nu reto slim\u012bbu jom\u0101 gandar\u012bta, bet ba\u017e\u012bga par finans\u0113juma garantiju tr\u016bkumu - Medikamentu Inform\u0101cijas Centrs","description":"Latvijas Reto slim\u012bbu alianse ir gandar\u012bta par vald\u012bb\u0101 apstiprin\u0101to pl\u0101nu reto slim\u012bbu jom\u0101 2026.-2027. gadam, ta\u010du ba\u017e\u012bjas par t\u0101 \u012bsteno\u0161anai nepiecie\u0161am\u0101 finans\u0113juma garantiju tr\u016bkumu, a\u0123ent\u016brai LETA pauda alianses valdes priek\u0161s\u0113d\u0113t\u0101js Juris Beikmanis. Alianse piedal\u012bjusies pl\u0101na izstr\u0101des proces\u0101, t\u0101d\u0113\u013c esot liels prieks, ka dokuments beidzot apstiprin\u0101ts. Reiz\u0113 Beikmanis nor\u0101d\u012bja, ka vismaz pusgadu, iesp\u0113jams, pat ilg\u0101k gaid\u012bts,","canonical_url":"https:\/\/farmacija-mic.lv\/en\/reto-slimibu-alianse-par-apstiprinato-planu-reto-slimibu-joma-gandarita-bet-baziga-par-finansejuma-garantiju-trukumu\/","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BreadcrumbList","@id":"https:\/\/farmacija-mic.lv\/en\/reto-slimibu-alianse-par-apstiprinato-planu-reto-slimibu-joma-gandarita-bet-baziga-par-finansejuma-garantiju-trukumu\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/en\/#listItem","position":1,"name":"Home","item":"https:\/\/farmacija-mic.lv\/en\/","nextItem":{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/category\/medikamentu-zinas\/#listItem","name":"Medikamenti"}},{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/category\/medikamentu-zinas\/#listItem","position":2,"name":"Medikamenti","item":"https:\/\/farmacija-mic.lv\/category\/medikamentu-zinas\/","nextItem":{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/en\/reto-slimibu-alianse-par-apstiprinato-planu-reto-slimibu-joma-gandarita-bet-baziga-par-finansejuma-garantiju-trukumu\/#listItem","name":"Reto slim\u012bbu alianse par apstiprin\u0101to pl\u0101nu reto slim\u012bbu jom\u0101 gandar\u012bta, bet ba\u017e\u012bga par finans\u0113juma garantiju tr\u016bkumu"},"previousItem":{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/en\/#listItem","name":"Home"}},{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/en\/reto-slimibu-alianse-par-apstiprinato-planu-reto-slimibu-joma-gandarita-bet-baziga-par-finansejuma-garantiju-trukumu\/#listItem","position":3,"name":"Reto slim\u012bbu alianse par apstiprin\u0101to pl\u0101nu reto slim\u012bbu jom\u0101 gandar\u012bta, bet ba\u017e\u012bga par finans\u0113juma garantiju tr\u016bkumu","previousItem":{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/category\/medikamentu-zinas\/#listItem","name":"Medikamenti"}}]},{"@type":"NewsArticle","@id":"https:\/\/farmacija-mic.lv\/en\/reto-slimibu-alianse-par-apstiprinato-planu-reto-slimibu-joma-gandarita-bet-baziga-par-finansejuma-garantiju-trukumu\/#newsarticle","name":"Reto slim\u012bbu alianse par apstiprin\u0101to pl\u0101nu reto slim\u012bbu jom\u0101 gandar\u012bta, bet ba\u017e\u012bga par finans\u0113juma garantiju tr\u016bkumu - Medikamentu Inform\u0101cijas Centrs","headline":"Reto slim\u012bbu alianse par apstiprin\u0101to pl\u0101nu reto slim\u012bbu jom\u0101 gandar\u012bta, bet ba\u017e\u012bga par finans\u0113juma garantiju tr\u016bkumu","author":{"@id":"https:\/\/farmacija-mic.lv\/en\/author\/admin\/#author"},"publisher":{"@id":"https:\/\/farmacija-mic.lv\/en\/#organization"},"image":{"@type":"ImageObject","url":"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/2023\/01\/reto-slimibu-pacients-patient.png","width":1000,"height":667},"datePublished":"2026-08-21T09:18:20+03:00","dateModified":"2026-08-21T09:18:20+03:00","inLanguage":"en-US","mainEntityOfPage":{"@id":"https:\/\/farmacija-mic.lv\/en\/reto-slimibu-alianse-par-apstiprinato-planu-reto-slimibu-joma-gandarita-bet-baziga-par-finansejuma-garantiju-trukumu\/#webpage"},"isPartOf":{"@id":"https:\/\/farmacija-mic.lv\/en\/reto-slimibu-alianse-par-apstiprinato-planu-reto-slimibu-joma-gandarita-bet-baziga-par-finansejuma-garantiju-trukumu\/#webpage"},"articleSection":"Jaun\u0101kie raksti, Medikamenti, Beikmanis, ret\u0101s slim\u012bbas","dateline":"Published on August 21, 2026."},{"@type":"Organization","@id":"https:\/\/farmacija-mic.lv\/en\/#organization","name":"Medikamentu Inform\u0101cijas Centrs","description":"Farm\u0101cijas nozares port\u0101ls farmaceitiem un \u0101rstiem. Zi\u0146as, normat\u012bvie akti, pas\u0101kumi un t\u0101l\u0101kizgl\u012bt\u012bba vienuviet kop\u0161 2001. gada.","url":"https:\/\/farmacija-mic.lv\/en\/"},{"@type":"Person","@id":"https:\/\/farmacija-mic.lv\/en\/author\/admin\/#author","url":"https:\/\/farmacija-mic.lv\/en\/author\/admin\/","name":"admin","image":{"@type":"ImageObject","@id":"https:\/\/farmacija-mic.lv\/en\/reto-slimibu-alianse-par-apstiprinato-planu-reto-slimibu-joma-gandarita-bet-baziga-par-finansejuma-garantiju-trukumu\/#authorImage","url":"https:\/\/secure.gravatar.com\/avatar\/be3221a6fac131657111728b4d912a877ec158b123d5db3afef3bd8a59784ece?s=96&d=mm&r=g","width":96,"height":96,"caption":"admin"}},{"@type":"WebPage","@id":"https:\/\/farmacija-mic.lv\/en\/reto-slimibu-alianse-par-apstiprinato-planu-reto-slimibu-joma-gandarita-bet-baziga-par-finansejuma-garantiju-trukumu\/#webpage","url":"https:\/\/farmacija-mic.lv\/en\/reto-slimibu-alianse-par-apstiprinato-planu-reto-slimibu-joma-gandarita-bet-baziga-par-finansejuma-garantiju-trukumu\/","name":"Reto slim\u012bbu alianse par apstiprin\u0101to pl\u0101nu reto slim\u012bbu jom\u0101 gandar\u012bta, bet ba\u017e\u012bga par finans\u0113juma garantiju tr\u016bkumu - Medikamentu Inform\u0101cijas Centrs","description":"Latvijas Reto slim\u012bbu alianse ir gandar\u012bta par vald\u012bb\u0101 apstiprin\u0101to pl\u0101nu reto slim\u012bbu jom\u0101 2026.-2027. gadam, ta\u010du ba\u017e\u012bjas par t\u0101 \u012bsteno\u0161anai nepiecie\u0161am\u0101 finans\u0113juma garantiju tr\u016bkumu, a\u0123ent\u016brai LETA pauda alianses valdes priek\u0161s\u0113d\u0113t\u0101js Juris Beikmanis. Alianse piedal\u012bjusies pl\u0101na izstr\u0101des proces\u0101, t\u0101d\u0113\u013c esot liels prieks, ka dokuments beidzot apstiprin\u0101ts. Reiz\u0113 Beikmanis nor\u0101d\u012bja, ka vismaz pusgadu, iesp\u0113jams, pat ilg\u0101k gaid\u012bts,","inLanguage":"en-US","isPartOf":{"@id":"https:\/\/farmacija-mic.lv\/en\/#website"},"breadcrumb":{"@id":"https:\/\/farmacija-mic.lv\/en\/reto-slimibu-alianse-par-apstiprinato-planu-reto-slimibu-joma-gandarita-bet-baziga-par-finansejuma-garantiju-trukumu\/#breadcrumblist"},"author":{"@id":"https:\/\/farmacija-mic.lv\/en\/author\/admin\/#author"},"creator":{"@id":"https:\/\/farmacija-mic.lv\/en\/author\/admin\/#author"},"image":{"@type":"ImageObject","url":"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/2023\/01\/reto-slimibu-pacients-patient.png","@id":"https:\/\/farmacija-mic.lv\/en\/reto-slimibu-alianse-par-apstiprinato-planu-reto-slimibu-joma-gandarita-bet-baziga-par-finansejuma-garantiju-trukumu\/#mainImage","width":1000,"height":667},"primaryImageOfPage":{"@id":"https:\/\/farmacija-mic.lv\/en\/reto-slimibu-alianse-par-apstiprinato-planu-reto-slimibu-joma-gandarita-bet-baziga-par-finansejuma-garantiju-trukumu\/#mainImage"},"datePublished":"2026-08-21T09:18:20+03:00","dateModified":"2026-08-21T09:18:20+03:00"},{"@type":"WebSite","@id":"https:\/\/farmacija-mic.lv\/en\/#website","url":"https:\/\/farmacija-mic.lv\/en\/","name":"Medikamentu Inform\u0101cijas Centrs","description":"Farm\u0101cijas nozares port\u0101ls farmaceitiem un \u0101rstiem. Zi\u0146as, normat\u012bvie akti, pas\u0101kumi un t\u0101l\u0101kizgl\u012bt\u012bba vienuviet kop\u0161 2001. gada.","inLanguage":"en-US","publisher":{"@id":"https:\/\/farmacija-mic.lv\/en\/#organization"}}]},"og:locale":"en_US","og:site_name":"Medikamentu Inform\u0101cijas Centrs","og:type":"article","og:title":"Reto slim\u012bbu alianse par apstiprin\u0101to pl\u0101nu reto slim\u012bbu jom\u0101 gandar\u012bta, bet ba\u017e\u012bga par finans\u0113juma garantiju tr\u016bkumu - Medikamentu Inform\u0101cijas Centrs","og:description":"Latvijas Reto slim\u012bbu alianse ir gandar\u012bta par vald\u012bb\u0101 apstiprin\u0101to pl\u0101nu reto slim\u012bbu jom\u0101 2026.-2027. gadam, ta\u010du ba\u017e\u012bjas par t\u0101 \u012bsteno\u0161anai nepiecie\u0161am\u0101 finans\u0113juma garantiju tr\u016bkumu, a\u0123ent\u016brai LETA pauda alianses valdes priek\u0161s\u0113d\u0113t\u0101js Juris Beikmanis. Alianse piedal\u012bjusies pl\u0101na izstr\u0101des proces\u0101, t\u0101d\u0113\u013c esot liels prieks, ka dokuments beidzot apstiprin\u0101ts. Reiz\u0113 Beikmanis nor\u0101d\u012bja, ka vismaz pusgadu, iesp\u0113jams, pat ilg\u0101k gaid\u012bts,","og:url":"https:\/\/farmacija-mic.lv\/en\/reto-slimibu-alianse-par-apstiprinato-planu-reto-slimibu-joma-gandarita-bet-baziga-par-finansejuma-garantiju-trukumu\/","og:image":"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/2023\/01\/reto-slimibu-pacients-patient.png","og:image:secure_url":"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/2023\/01\/reto-slimibu-pacients-patient.png","og:image:width":1000,"og:image:height":667,"article:published_time":"2026-08-21T07:18:20+00:00","article:modified_time":"2026-08-21T07:18:20+00:00","twitter:card":"summary_large_image","twitter:title":"Reto slim\u012bbu alianse par apstiprin\u0101to pl\u0101nu reto slim\u012bbu jom\u0101 gandar\u012bta, bet ba\u017e\u012bga par finans\u0113juma garantiju tr\u016bkumu - Medikamentu Inform\u0101cijas Centrs","twitter:description":"Latvijas Reto slim\u012bbu alianse ir gandar\u012bta par vald\u012bb\u0101 apstiprin\u0101to pl\u0101nu reto slim\u012bbu jom\u0101 2026.-2027. gadam, ta\u010du ba\u017e\u012bjas par t\u0101 \u012bsteno\u0161anai nepiecie\u0161am\u0101 finans\u0113juma garantiju tr\u016bkumu, a\u0123ent\u016brai LETA pauda alianses valdes priek\u0161s\u0113d\u0113t\u0101js Juris Beikmanis. Alianse piedal\u012bjusies pl\u0101na izstr\u0101des proces\u0101, t\u0101d\u0113\u013c esot liels prieks, ka dokuments beidzot apstiprin\u0101ts. Reiz\u0113 Beikmanis nor\u0101d\u012bja, ka vismaz pusgadu, iesp\u0113jams, pat ilg\u0101k gaid\u012bts,","twitter:image":"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/2023\/01\/reto-slimibu-pacients-patient.png"},"aioseo_meta_data":{"post_id":"22831","title":null,"description":null,"keywords":null,"keyphrases":null,"focus_keyword":null,"additional_keywords":null,"truseo_locale":null,"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_custom_url":null,"og_image_custom_fields":null,"og_image_url":null,"og_image_width":null,"og_image_height":null,"og_video":null,"og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_image_url":null,"twitter_title":null,"twitter_description":null,"schema_type":"default","schema_type_options":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"","isEnabled":true},"graphs":[]},"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":null,"robots_max_videopreview":null,"robots_max_imagepreview":"large","priority":null,"frequency":null,"local_seo":null,"limit_modified_date":false,"ai":null,"breadcrumb_settings":null,"seo_analyzer_scan_date":null,"created":"2026-10-16 20:00:06","updated":"2026-10-16 20:00:06"},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/farmacija-mic.lv\/en\/\" title=\"Home\">Home<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/farmacija-mic.lv\/category\/medikamentu-zinas\/\" title=\"Medikamenti\">Medikamenti<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\tReto slim\u012bbu alianse par apstiprin\u0101to pl\u0101nu reto slim\u012bbu jom\u0101 gandar\u012bta, bet ba\u017e\u012bga par finans\u0113juma garantiju tr\u016bkumu\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/farmacija-mic.lv\/en\/"},{"label":"Medikamenti","link":"https:\/\/farmacija-mic.lv\/category\/medikamentu-zinas\/"},{"label":"Reto slim\u012bbu alianse par apstiprin\u0101to pl\u0101nu reto slim\u012bbu jom\u0101 gandar\u012bta, bet ba\u017e\u012bga par finans\u0113juma garantiju tr\u016bkumu","link":"https:\/\/farmacija-mic.lv\/en\/reto-slimibu-alianse-par-apstiprinato-planu-reto-slimibu-joma-gandarita-bet-baziga-par-finansejuma-garantiju-trukumu\/"}],"_links":{"self":[{"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/posts\/22831","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/comments?post=22831"}],"version-history":[{"count":0,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/posts\/22831\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/media\/13491"}],"wp:attachment":[{"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/media?parent=22831"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/categories?post=22831"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/tags?post=22831"},{"taxonomy":"mic_flag","embeddable":true,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/mic_flag?post=22831"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}